Integrated DNA Technologies Opens Business Unit and Launches New Products
News May 20, 2008
Integrated DNA Technologies (IDT) has announced that it has opened a new business unit dedicated to the manufacture of oligonucleotides for use in diagnostic products.
The company has been awarded ISO 13485:2003 certification at its Coralville facility, for its new business unit called “Clinical and Commercial Manufacturing” (CCM).
This globally recognized certificate confirms that IDT meets the rigorous standards required for the supply of custom manufacturing/processing services, customer support and sales distribution of molecular biology products for molecular in vitro diagnostic devices and licensed nucleic acid tests. This covers its synthetic oligonucleotides as well as the associated reagents and consumables.
Bill Jones, Director of Quality Assurance for IDT, said, “This dedicated manufacturing suite, with its additional ISO 13485 certification and compliance with FDA 21 CFR Part 820 QSR/cGMP, positions IDT to better serve both our current and future clinical/medical device customers. It will also be important for other commercial customers with applications that need a higher level of process control and compliance.”
The ISO 13485:2003 certification and subsequent registration of the facility with the FDA, follows a series of audits - carried out by BSI Management Systems, a prominent quality management systems registrar - requiring on-site assessments, examinations of IDT's documented procedures, and an audit of overall operations.
System quality is then monitored through periodic surveillance audits of IDT's processes, by BSI Management Systems. As a result the ISO 13485:2003 certification provides a clear, recognized, and highly respected standard for quality management in the highly regulated clinical/medical market.
In addition, the company announced the availability of an entire suite of fluorescent dyes and quenchers that can be used in diagnostic products, which require no additional licensing from IDT or third parties.
The so-called Freedom Dye program currently provides ten fluorescent dyes and companion dye-quenchers that can be used by CCM clients as ready replacements for royalty-bearing dyes and quenchers in-licensed from third parties.
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018